Skip to main content

Avoro Capital Advisors LLC

Location
NEW YORK, NY
Portfolio Value
Mid $6,750,104,056
Diversification
Diversified
Filing Date
Global Rank
#547 / 7,976 ▲ 90
Top Industry
Biotechnology 85.1%
3Y Alpha vs SPY
-4.2%
Period ended 9 months ago
Filed Nov 14, 2025 · 7mo
23 quarters · since Mar 2020

Clone Performance

Jun 2023–Jun 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
+58.7%
SPY
+76.3%
Annualised alpha
-4.2%
Max drawdown
−30.0%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

25 positions · as of Sep 30, 2025 · Δ vs Jun 30, 2025
Top Position
15.1%
−2.1 pts
Top 5
59.4%
−3.0 pts
Top 10
82.1%
−1.0 pts
HHI
886
Dec 2022 → Sep 2025 · range 567 – 953
Diversified−67

Portfolio Trend

23 quarters · across all stocks

Sector Breakdown

As of Sep 30, 2025
Sector % Portfolio Value
Healthcare 100.0% $6,750,104,056

Last Quarter's Activity

Export CSV
Sep 30, 2025 vs Jun 30, 2025

Added To

Positions the filer increased
8 positions
Ticker Δ Shares Shares Value Open

Trimmed

Positions the filer reduced
10 positions
Ticker Δ Shares Shares Value Open

New Positions

Positions the filer opened this quarter
3 positions
Ticker Shares Value Open

Sold Out

Positions the filer fully exited
2 positions
Ticker Shares Value Open

Portfolio Positions

Export CSV View 13F filing
25 positions · $6,750,104,056 total · as of Sep 30, 2025
Ticker Company Shares Value (USD) % of Portfolio History